UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 24, 2021
Enphys Acquisition Corp.
(Exact name of registrant as specified in charter)
|
Cayman Islands
|
001-40879
|
87-2010879
|
|
(State or other jurisdiction of incorporation)
|
Commission File number
|
(I.R.S. Employer Identification Number)
|
|
216 East 45th Street
13th Floor
New York, New York
|
|
10017 |
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(347) 467-0441
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
|
Units, each consisting of one share of Class A ordinary shares and one-half of one redeemable warrant
|
|
NFYS.U
|
|
New York Stock Exchange
|
| |
|
| |
|
|
Class A ordinary shares, par value $0.0001 per share
|
|
NFYS
|
|
New York Stock Exchange
|
| |
|
|
Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary shares at an exercise price of $11.50
|
|
NFYS.WS
|
|
New York Stock Exchange
|
| |
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
As previously reported, on October 8, 2021, Enphys Acquisition Corp. (the “Company”) consummated its initial public offering (“IPO”) of 34,500,000 units (the “Units”), including the issuance of 4,500,000 Units as a result of the
underwriters’ exercise of their over-allotment option. Each Unit consists of one share of Class A ordinary shares of the Company, par value of $0.0001 per share (“Class A Ordinary Shares”), and one-half of one redeemable warrant of the Company (a
“Warrant”), with each whole Warrant entitling the holder thereof to purchase one share of Class A Ordinary Shares. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the
Company of $345,000,000.
On November 24, 2021, the Company issued a press release, a copy of which is attached as Exhibit 99.1 to this Current Report on
Form 8-K, announcing that the holders of the Units may elect to separately trade shares of the Class A Ordinary Shares and Warrants comprising the Units commencing on November 26, 2021. Those Units not separated will continue to trade on the New
York Stock Exchange under the symbol “NFYS.U,” and the Class A Ordinary Shares and Warrants that are separated will trade on the New York Stock Exchange under the symbols “NFYS” and “NFYS.WS,” respectively. Holders of Units will need to have their
brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate Units into shares of Class A Ordinary Shares and Warrants.
| Item 9.01. |
Financial Statements and Exhibits
|
(d) Exhibits. The following exhibits are filed with this Form 8-K:
|
Exhibit No.
|
|
Description of Exhibits
|
| |
|
|
99.1
|
|
Press Release, dated November 24, 2021.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
| |
Enphys Acquisition Corp.
|
| |
|
|
|
Date: November 24, 2021
|
By:
|
/s/ Jorge de Pablo
|
| |
Name:
|
Jorge de Pablo
|
| |
Title:
|
Chief Executive Officer
|